Literature DB >> 2981364

Effect of immunosuppression on experimental Argentine hemorrhagic fever in guinea pigs.

R H Kenyon, D E Green, C J Peters.   

Abstract

Immunosuppression with cyclosporin A or cyclophosphamide had no apparent effect on the disease course of guinea pigs infected with a virulent strain of Junin virus. Immunosuppression of guinea pigs infected with an attenuated strain of Junin virus led to fulminating Argentine hemorrhagic fever. All immunosuppressed infected animals died. Virus distribution patterns in target organs, as determined by plaque assay and fluorescent antibody procedures, were similar to those from non-immunosuppressed animals infected with a virulent strain. Histopathological lesions in immunosuppressed guinea pigs infected with an attenuated strain of virus were similar to those in non-immunosuppressed guinea pigs infected with a virulent strain. Histological changes attributable to the immunosuppressive drug(s) were regularly observed. Immunosuppressed animals infected with attenuated Junin virus and non-immunosuppressed animals infected with virulent virus failed to develop antibody or responded at a minimal level. Virus-specific cytotoxic spleen cell activity, previously shown to be antibody dependent, failed to develop in the same animals. The presence of a competent immune response, probably serum antibody, determined whether Argentine hemorrhagic fever infection of the guinea pig was lethal or whether recovery ensued; no evidence for harmful effects of the immune response was obtained.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981364      PMCID: PMC254980     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome.

Authors:  J I Maiztegui; N J Fernandez; A J de Damilano
Journal:  Lancet       Date:  1979-12-08       Impact factor: 79.321

2.  [Action of immune sera in experimental hemorrhagic fever].

Authors:  M Weissenbacher; L B De Guerrero; A S Parodi
Journal:  Medicina (B Aires)       Date:  1968 Mar-Apr       Impact factor: 0.653

3.  Junin virus infection of guinea pigs: immunohistochemical and ultrastructural studies of hemopoietic tissue.

Authors:  G Carballal; P M Cossio; R P Laguens; C Ponzinibbio; J R Oubiña; P C Meckert; A Rabinovich; R M Arana
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

Review 4.  Immunobiology of cyclosporin A--a review.

Authors:  A W Thomson
Journal:  Aust J Exp Biol Med Sci       Date:  1983-04

5.  [Viral persistence and absence of brain lesions in congenitally athymic mice infected with Junin virus].

Authors:  M C Weissenbacher; R P Laguens; C J Quintans; M A Calello; L Montoro; N M Woyskowsky; V H Zannoli
Journal:  Medicina (B Aires)       Date:  1983       Impact factor: 0.653

6.  Inhibition of human natural killer activity by cyclosporin A.

Authors:  M Introna; P Allavena; F Spreafico; A Mantovani
Journal:  Transplantation       Date:  1981-02       Impact factor: 4.939

7.  Immunosuppression in experimental Junin virus infection of mice.

Authors:  O A Giovanniello; M R Nejamkis; N V Galassi; N R Nota
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

8.  Pathogenesis of Lassa virus infection in guinea pigs.

Authors:  P B Jahrling; S Smith; R A Hesse; J B Rhoderick
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  New attenuation marker for junin virus based on immunologic responses of guinea pigs.

Authors:  N V Galassi; J L Blejer; H Barrios; M R Nejamkis; N R Nota
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

10.  Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs.

Authors:  P B Jahrling; R A Hesse; J B Rhoderick; M A Elwell; J B Moe
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

View more
  7 in total

1.  Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs.

Authors:  R H Kenyon; P G Canonico; D E Green; C J Peters
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

2.  Heterogeneity of Junin virus strains.

Authors:  R H Kenyon; K T McKee; J I Maiztegui; D E Green; C J Peters
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

3.  Immunosuppression-induced susceptibility of inbred hamsters (Mesocricetus auratus) to lethal-disease by lymphocytic choriomeningitis virus infection.

Authors:  E V Genovesi; C J Peters
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Gene expression in primate liver during viral hemorrhagic fever.

Authors:  Mahmoud Djavani; Oswald R Crasta; Yan Zhang; Juan Carlos Zapata; Bruno Sobral; Melissa G Lechner; Joseph Bryant; Harry Davis; Maria S Salvato
Journal:  Virol J       Date:  2009-02-12       Impact factor: 4.099

5.  Type I interferon underlies severe disease associated with Junín virus infection in mice.

Authors:  Brady T Hickerson; Eric J Sefing; Kevin W Bailey; Arnaud J Van Wettere; Manuel L Penichet; Brian B Gowen
Journal:  Elife       Date:  2020-05-26       Impact factor: 8.140

Review 6.  Junín virus pathogenesis and virus replication.

Authors:  Ashley Grant; Alexey Seregin; Cheng Huang; Olga Kolokoltsova; Allan Brasier; Clarence Peters; Slobodan Paessler
Journal:  Viruses       Date:  2012-10-19       Impact factor: 5.048

Review 7.  Differential Immune Responses to Hemorrhagic Fever-Causing Arenaviruses.

Authors:  Emily Mantlo; Slobodan Paessler; Cheng Huang
Journal:  Vaccines (Basel)       Date:  2019-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.